上证早知道｜重要预告：周三下午3时；激光雷达龙头，拿下大订单；事关高端医疗器械；上海部署

Group 1 - The Shanghai Municipal Government has issued an action plan to promote the full-chain development of the high-end medical device industry, aiming to approve over 500 new Class III medical device registrations domestically and over 100 products in overseas markets by 2027, with a target annual output value exceeding 10 billion yuan [8][9] - Hesai Technology has signed a laser radar order worth over 40 million USD with a leading US Robotaxi company, planning to deliver the order by the end of 2026 [10] - The insurance and pension funds have heavily invested over 1 billion yuan in the Guolian An CSI A500 Dividend Low Volatility ETF, with insurance institutions holding 92.27% of the total fund shares [6] Group 2 - Junsheng Electronics has received project notifications from two leading automotive manufacturers, with an estimated total order value of approximately 15 billion yuan, set to begin mass production in 2027 [14] - Borui Pharmaceutical has received approval for clinical trials of its weight loss drug BGM0504, which is a dual agonist of GLP-1 and GIP receptors, targeting obesity and non-alcoholic fatty liver disease [15][16] - Jingchen Technology plans to acquire 100% equity of Chip Micro Semiconductor for 316 million yuan, enhancing its capabilities in IoT and automotive sectors [17]